Revision as of 05:58, 13 October 2019 editCitation bot (talk | contribs)Bots5,421,381 editsm Alter: journal. | You can use this bot yourself. Report bugs here.| Activated by User:Headbomb | via #UCB_Headbomb← Previous edit | Latest revision as of 18:21, 3 June 2020 edit undoFswitzer4 (talk | contribs)Extended confirmed users10,572 editsm Validated CAS and added FDA UNII | ||
Line 20: | Line 20: | ||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | ||
| StdInChIKey = OJOLFAIGOXZBCI-UHFFFAOYSA-N | | StdInChIKey = OJOLFAIGOXZBCI-UHFFFAOYSA-N | ||
| CASNo_Ref = {{cascite| |
| CASNo_Ref = {{cascite|correct|CAS}} | ||
| CASNo=2464-23-5 | | CASNo=2464-23-5 | ||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 5Z1F5OW4YB | |||
| PubChem=98 | | PubChem=98 | ||
| ChEBI_Ref = {{ebicite|correct|EBI}} | | ChEBI_Ref = {{ebicite|correct|EBI}} |
Latest revision as of 18:21, 3 June 2020
Names | |
---|---|
Preferred IUPAC name 2-Oxo-3-sulfanylpropanoic acid | |
Other names
3-Mercapto-2-oxopropanoic acid 3-MPV 3-MP | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEBI | |
ChemSpider | |
IUPHAR/BPS | |
KEGG | |
MeSH | 3-mercaptopyruvic+acid |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C3H4O3S |
Molar mass | 120.12 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
3-Mercaptopyruvic acid is an intermediate in cysteine metabolism. It has been studied as a potential treatment for cyanide poisoning, but its half-life is too short for it to be clinically effective. Instead, prodrugs, such as sulfanegen, are being evaluated to compensate for the short half-life of 3-mercaptopyruvic acid.
See also
References
- Nagahara, N; Li, Q; Sawada, N (2003). "Do antidotes for acute cyanide poisoning act on mercaptopyruvate sulfurtransferase to facilitate detoxification?". Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 3 (3): 198–204. doi:10.2174/1568008033340162. PMID 12871026.
- Brenner, M; Kim, JG; Lee, J; Mahon, SB; Lemor, D; Ahdout, R; Boss, GR; Blackledge, W; Jann, L; Nagasawa, HT; Patterson, SE (2010). "Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity". Toxicology and Applied Pharmacology. 248 (3): 269–76. doi:10.1016/j.taap.2010.08.002. PMC 3382974. PMID 20705081.
This article about an organic compound is a stub. You can help Misplaced Pages by expanding it. |